NRIX - Nurix Therapeutics, Inc.
IEX Last Trade
19.54
-0.070 -0.358%
Share volume: 940
Last Updated: Fri 27 Dec 2024 03:30:33 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$19.61
-0.07
-0.36%
View ratios
| Fiscal Date | 2022-08-31 | 2022-11-30 | 2023-02-28 | 2023-05-31 | 2023-08-31 | 2023-11-30 | 2024-02-29 | 2024-05-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-06 | 2023-02-09 | 2023-04-13 | 2023-07-13 | 2023-10-12 | 2024-02-15 | 2024-04-10 | 2024-07-11 | |
| Total revenue | 10.791 M | 6.783 M | 12.685 M | 30.676 M | 18.467 M | 15.159 M | 16.585 M | 12.092 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 10.791 M | 6.783 M | 12.685 M | 30.676 M | 18.467 M | 15.159 M | 16.585 M | 12.092 M | |
| -37.14% | 87.01% | 141.83% | -39.80% | -17.91% | 9.41% | -27.09% | |||
| Operating expenses | 57.509 M | 55.473 M | 55.637 M | 57.441 M | 58.479 M | 60.493 M | 61.804 M | 60.632 M | |
| Selling general and admin | 9.748 M | 9.367 M | 9.821 M | 11.678 M | 10.623 M | 10.780 M | 11.799 M | 11.710 M | |
| Research and development | 47.761 M | 46.106 M | 45.816 M | 45.763 M | 47.856 M | 49.713 M | 50.005 M | 48.922 M | |
| Total expenses | 57.509 M | 55.473 M | 55.637 M | 57.441 M | 58.479 M | 60.493 M | 61.804 M | 60.632 M | |
| -3.54% | 0.30% | 3.24% | 1.81% | 3.44% | 2.17% | -1.90% | |||
| Operating income | -46.718 M | -48.690 M | -42.952 M | -26.765 M | -40.012 M | -45.334 M | -45.219 M | -48.540 M | |
| Ebit | -46.718 M | -48.690 M | -42.952 M | -26.765 M | -40.012 M | -45.334 M | -45.219 M | -48.540 M | |
| Pretax income | -45.709 M | -46.717 M | -40.733 M | -24.277 M | -36.982 M | -41.956 M | -41.428 M | -44.456 M | |
| 2.21% | -12.81% | -40.40% | 52.33% | 13.45% | -1.26% | 7.31% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 90.000 K | 90.000 K | |
| Net income basic | -45.709 M | -46.717 M | -40.733 M | -24.277 M | -36.982 M | -41.956 M | -41.518 M | -44.546 M | |
| -2.21% | 12.81% | 40.40% | -52.33% | -13.45% | 1.04% | -7.29% | |||
| Net income | -45.709 M | -46.717 M | -40.733 M | -24.277 M | -36.982 M | -41.956 M | -41.518 M | -44.546 M | |
| -2.21% | 12.81% | 40.40% | -52.33% | -13.45% | 1.04% | -7.29% |